Skip to content

The 308 nm excimer laser can be used to treat plaque psoriasis,4 vitiligo4,5 and early-stage mycosis fungoides

The 308 nm excimer laser can be used to treat plaque psoriasis,4 vitiligo4,5 and early-stage mycosis fungoides 1

308-nm excimer laser has currently a verified efficacy in treating skin conditions such as vitiligo, psoriasis, atopic dermatitis, alopecia areata, allergic rhinitis, folliculitis, granuloma annulare, lichen planus, mycosis fungoides, palmoplantar pustulosis, pityriasis alba, CD30+ lympho proliferative disorder, leukoderma, prurigo nodularis, localized scleroderma and genital lichen sclerosus. Notable abrogation of psoriasis plaques has been noted even following the first session of excimer laser phototherapy which also sustains subsequent to treatment tapering 26, 27. Receiving 308-nm excimer laser as a mode of therapy has shown promising results in early-stage localized mycosis fungoides. 2011;303:6234. Mycosis fungoides (MF) is the most common form of cutaneous T-cell lymphoma. Of the various phototherapeutic options, PUVA and NBUVB have been used as the most common phototherapies for patch and plaque MF. Phototherapy is the use of UV radiation in the treatment of skin disease.

The 308 nm excimer laser can be used to treat plaque psoriasis,4 vitiligo4,5 and early-stage mycosis fungoides 2Phototherapy is a safe and effective treatment for psoriasis. Use commas. Early-stage mycosis fungoides (MF) is most commonly treated with skin-directed therapies such as topical steroids, phototherapy (broadband or narrowband UVB), photochemotherapy (psoralen plus UVA), topical nitrogen mustard, and total skin electron-beam irradiation. Recently, several small studies have demonstrated the efficacy of the 308-nm excimer laser in the treatment of early-stage MF. Drug Administration to treat psoriasis since 1997 and to treat vitiligo since 2001. Since the 308nm velocity excimer laser delivers high dose, targeted narrow-band UVB phototherapy, it is a viable treatment option for these patients. We report herein a case of a single recalcitrant psoriasiform plaque with ambiguous histology, in a patient with history of patch-stage mycosis fungoides, treated successfully with the 308nm excimer laser. Differential diagnosis included psoriasis, early plaque-stage MF, tinea, and syphilis. 2000 May;136(5):619-24.

The use of UVA tanning salon treatments in the therapy of psoriasis is usually unsuccessful and is extremely unwise with concomitant psoralen and drug therapy. Phototherapy can be in the form of 311-nm UVB or UVA1 irradiation. UVB therapy for small plaque parapsoriasis and early-stage mycosis fungoides. 308 nm excimer light was used at a power density of 48 mW/cm2. MEL 308 nm can be. Keywords: Excimer laser, excimer light, phototherapy, psoriasis, targeted phototherapy, vitiligo. Introduction. Phototherapy is used for a wide variety of skin diseases.

Phototherapy And Photochemotherapy (puva) For Skin Conditions

The 308 nm excimer laser can be used to treat plaque psoriasis,4 vitiligo4,5 and early-stage mycosis fungoides 3The excimer light source used in the study (MEL, Excilite TM. In the early 1980s, the observation that wavelengths around 311 nm were more effective. Narrowband UVB has since become the type of phototherapy most frequently used for the treatment of psoriasis and a wide range of skin diseases, including atopic dermatitis, vitiligo, early stages of mycosis fungoides, and pruritic disorders (table 1) 3,4. Comparison of the 308-nm excimer laser and a 308-nm excimer lamp with 311-nm narrowband ultraviolet B in the treatment of psoriasis. Article: Controlled study of Excimer and pulsed dye lasers in the treatment of psoriasis. Use as a treatment option for atopic dermatitis, mycosis fungoides, acne, scleroderma, vitiligo, and pruritus, as well as other UV sensitive dermatoses, may also be beneficial. Mycosis fungoides Phototherapy Pruritus Psoriasis Tanning beds. 2004;195(3):298308. Br J Dermatol 162: 5. V Nikolaou, M P Siakantaris, T P Vassilakopoulos, E Papadavid, A Stratigos, A Economidi, L Marinos, T Papadaki, C Antoniou (2010) PUVA plus interferon alpha2b in the treatment of advanced or refractory to PUVA early stage mycosis fungoides: a case series. 213-4; discussion 214 Mar. In use today are narrowband and broadband UVB, UVA as part of psoralen photochemotherapy (PUVA), UVA1 and targeted phototherapy (excimer lasers and nonlaser monochromatic excimer light sources). Narrowband UVB is currently preferred to treat psoriasis, other inflammatory skin diseases, and vitiligo.

Phototherapy And Photochemotherapy (puva) For Skin Conditions

Mycosis fungoides (MF) is the most common group of cutaneous T-cell lymphomas. 15 As no shortcut to this painstaking process could have been evolved till now, the median timelag between onset of symptoms and diagnosis remains 4-6 years. It is a variant of patch stage or early plaque stage disease (grade 1). 103 On the heels of reports claiming beneficial response with 311 nm UVB, a 308 nm monochromatic excimer light, a new kind of xenon chloride lamp, has been claimed to be successful in stage IA MF.